|
|
|
|
|
Table Of Contents Physicians Academy Apr 2018 ( Volume -12 Number -4)
|
 | |  | | Article 1 Introduction of DMS irrigation to heal Endo–Perio lesions and Cysts This
article discusses the introduction of DMS Irrigation Solution (Doxycycline,
Metronidazole and Saline). It is an antibiotic solution, which can be pushed
beyond the Periapical region to treat the Perio-Endo Lesions, Furcation,
Fistula and even a big cyst of diameter 10 to 12 cm without causing any
complications. The case study has been done in Sabya General Hospital,
Jizan, Saudi Arabia in patients of the age group 18 to 55 after their proper
consent. Only female cases were
taken up for the study. Fifty
cases were treated and followed up. Among them 20 cases had periodontitis and
all of these had history of diabetes. During this procedure the DMS irrigation is used which directly flushes
the microbes providing enough dilution, irrigation and initiates the process of
healing, revascularization, regeneration and epithelialization of the
wound. Delivery system seems to be an efficient system in treating the
lesions; even of bigger diameters and DMS, as an irrigation seems to be the
most appropriate additional irrigation besides the conventional ones used in
dentistry. Download in pdf 302Kb  Darakshan Nabi Vakil, BDS
| |
|
Article 2 Alagille Syndrome in a Neonate Alagille syndrome (Alagille-Watson syndrome) is an
autosomal dominant genetic disorder that affects the liver, heart, kidney and
other systems of the body. Major contributors to
morbidity arise from bile duct paucity or cholestatic liver disease, underlying
cardiac disease. Males and females are affected equally. Problems associated
with the disorder generally become evident in infancy or childhood in our case
at birth. Prevalence of this syndrome is 1; 100,000 live births. Growth failure, delayed puberty and malnutrition are common in
children with Alagille syndrome. Children with Alagille syndrome have worse
growth failure than children with other chronic liver diseases, such as biliary
atresia. Download in pdf 168Kb  Ghulam Nabi, MD, Omar Al-Siyud, MD and Omar Nabi Siraj, MBBS
| |
|
Picture of The Month POTM-April 2018 This is the right foot of a 48 years old female suffering
from Type 2 DM for last one decade. She had a blister on it which became
painful and grayish four days after it erupted. She had used a hot water bottle
at night to tackle the extreme cold in winter in Kashmir. Can you guess what has happened?
 Download in pdf 181Kb  Sarosh Ahmed Khan, MBBS; MD; FACP
| |
|
Drug Update SEGLUROMET (ertugliflozin+metformin) SEGLUROMET
is a combination of ertugliflozin, a sodium glucose co-transporter 2 (SGLT2)
inhibitor, and metformin, a biguanide, indicated as an adjunct to diet and
exercise to improve glycemic control in adults with type 2 diabetes mellitus
who are not adequately controlled on a regimen containing ertugliflozin or
metformin, or in patients who are already treated with both ertugliflozin and
metformin. Download in pdf 545Kb 
| |
|
Abstracts from Other Journals Abstracts from Other Journals-April 2018 Use of
Acid-Suppressive Drugs, Antibiotics in Infancy Linked to Increased Allergy Risk JAMA Pediatrics Heart
Failure Patients, Sacubitril/Valsartan Improves Physical and Social Activities
Better Than Enalapril JAMA Cardiology Boys Who
Lose Excess Weight Lower Their Risk for Developing Type 2 Diabetes NEJM COPD Risk
Factors Evident Early in Life Lancet Respiratory
Medicine Physician's First
Watch coverage
of COPD guidelines
| |
|
| |  | |  |
|
|
 |
|
|
|
|
|
|
|
|
| | |
|
| |